Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-03-04 22:07:38

expired found date

-

created at

2024-06-06 00:50:09

updated at

2026-03-06 05:40:16

Domain name statistics

length

14

crc

52934

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

251948912

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

5

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

2026-03-22 13:40:16

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

73095

mp size raw text

3711

mp inner links count

4

mp inner links status

20 (imported)

Open Graph

title

home -

description

image

site name

author

updated

2025-12-16 09:50:22

raw text

home - contact home about our history management board of directors advisors approach pipeline news & insights presentations press releases references (PRL-02) references (CGS-200-5) careers contact Menu Menu bright ideas made brilliant Pioneering lymphatic targeting to address the limitations of current oncology therapies. about Propella at Propella Propella is employing a platform of medicinal chemistry and lymphatic targeting to create best-in-class oncology drugs starting from known actives that have validated mechanisms of action (MOAs) and biological targets.  Lymphatic targeting enables therapies to be delivered directly to targeted tissues via the lymphatic system thereby bypassing first-pass liver effects.  This approach provides increased bioavailability to tissues of interest including lymph nodes and bone metastatic sites, increased pharmacological activity, reduced liver effects, and an improved safety margin.  The company’s l...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Nowotwory (78)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

2917

text words

488

text unique words

244

text lines

80

text sentences

19

text paragraphs

6

text words per sentence

25

text matched phrases

6

text matched dictionaries

3

RSS

rss status

32 (unknown)

rss found date

2024-03-20 14:06:38

rss size orig

20385

rss items

10

rss spam phrases

0

rss detected language

1 (English)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

11 (sitemap processing suspended due to network errors, timeouts etc. - also set when domain_expired_found_date is set)

sitemap review version

1

sitemap urls count

42

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-03-20 07:10:11

sitemap process date

-

sitemap first import date

-

sitemap last import date

-